Parkinson's Disease
Volume 2015 (2015), Article ID 606810, 11 pages
http://dx.doi.org/10.1155/2015/606810

Research Article

Parkinson’s Disease and Home Healthcare Use and Expenditures among Elderly Medicare Beneficiaries

Sandipan Bhattacharjee,¹ Aaron Metzger,² Cindy Tworek,³ Wenhui Wei,⁴ Xiaoyun Pan,⁵ and Usha Sambamoorthi³

¹Department of Pharmacy Practice and Science, School of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA
²Department of Life-Span Developmental Psychology, West Virginia University, Morgantown, WV 26506, USA
³Department of Pharmaceutical Systems & Policy, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA
⁴Sanofi US, Bridgewater, NJ 08807, USA
⁵Evidera, Lexington, MA 02420, USA

Received 12 January 2015; Accepted 10 May 2015

Academic Editor: Hélio Teive

Copyright © 2015 Sandipan Bhattacharjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

This study estimated excess home healthcare use and expenditures among elderly Medicare beneficiaries (age ≥ 65 years) with Parkinson’s disease (PD) compared to those without PD and analyzed the extent to which predisposing, enabling, need factors, personal health choice, and external environment contribute to the excess home healthcare use and expenditures among individuals with PD. A retrospective, observational, cohort study design using Medicare 5% sample claims for years 2006-2007 was used for this study. Logistic regressions and Ordinary Least Squares regressions were used to assess the association of PD with home health use and expenditures, respectively. Postregression nonlinear and linear decomposition techniques were used to understand the extent to which differences in home healthcare use and expenditures among elderly Medicare beneficiaries with and without PD can be explained by individual-level factors. Elderly Medicare beneficiaries with PD had higher home health use and expenditures compared to those without PD. 27.5% and 18% of the gap in home health use and expenditures, respectively, were explained by differences in characteristics between the PD and no PD groups. A large portion of the differences in home healthcare use and expenditures remained unexplained.

1. Introduction

Elderly individuals with PD experience substantially higher healthcare expenditures compared to those without PD [1–4]. Specifically, home healthcare expenditures have been observed to be consistently and substantially higher among elderly individuals with PD compared to those without PD [1–4]. The magnitude of the difference in home healthcare expenditure varies depending on study population as well as the year in which the studies were conducted. Existing literature suggests that in the United States (US) the average annual home healthcare expenditures among elderly individuals with PD can be as high as 3.2 times more compared to those without PD [2]. Home healthcare use has also been shown to be higher among elderly individuals with PD compared to those without PD. Rates of home healthcare use have been observed to vary from twofold [1, 3] to more than threefold [2] higher among elderly individuals with PD compared to those without PD in the USA.

As PD has higher prevalence among elderly individuals (≥65 years) than among other age groups, most of the elderly living in the United States (US) are eligible for Medicare. Therefore, most of home healthcare spending will be borne by Medicare. It has been estimated that total Medicare home healthcare expenditures increased from $8.5 billion in 2000 to $18 billion in 2012, a 112% increase [5]. Because of the accelerated growth of home healthcare expenditures the Centers for Medicare and Medicaid Services (CMS) agency has been exploring ways to reduce the excess home healthcare expenditures. Thus, an understanding of factors contributing to home healthcare among all the elderly and specifically those with PD who are high utilizers of home healthcare is critical. However, to the best of authors’ knowledge, no study has analyzed various factors associated with higher home healthcare use and expenditures among individuals with PD. Therefore, the aims of this study were to (i) estimate excess home healthcare use and expenditures associated with PD, (ii) examine factors associated with excess home healthcare use and expenditures, and (iii) quantify the extent to which each of the different sets of factors explains excess home healthcare use and expenditures among individuals with PD compared to those without PD.

2. Methods

2.1. Conceptual Framework

The conceptual behavioral model by Andersen was used to examine the predisposing, enabling, need, personal health choices, and external environmental factors associated with the healthcare expenditures [6]. The Andersen Behavioral Model (ABM) has been used in various studies related to usage of health services (both healthcare use and expenditures). The ABM posits an individual’s use of health services as a function of (1) predisposing, (2) enabling, (3) need factors, (4) personal health choices, and (5) external environment. The individual’s characteristics that are predisposing include demographic characteristics (e.g., gender, age, and race/ethnicity). The ability of an individual to access a health service is termed as an enabling factor (e.g., public assistance). Need factors are represented either by a subjective acknowledgement of need such as a patient’s symptoms or by a professional’s judgment of the need for healthcare based on disease characteristics (e.g., number of comorbidities). Personal health choices (e.g., substance use) and external environment characteristics (e.g., census region, metro status) also influence an individual’s use of health services.

2.1.1. Study Design

We used a retrospective, observational, cohort study design with 12-month baseline and 12-month follow-up period. For the purposes of this study, Medicare 5% sample claims database for years 2006-2007 was used. Calendar year 2006 was considered as the baseline period and calendar year 2007 was considered as the follow-up period.

2.1.2. Data Source

The data were derived from the Medicare 5% sample, which contains all final action claims data for a random 5% sample of all claims of Medicare beneficiaries [7]. Available standard analytic files (SAF) in Medicare 5% sample claims database are (1) inpatient, (2) outpatient (encompassing claims from physician office), (3) skilled nursing facility, (4) carrier, (5) hospice care, (6) home health, and (7) durable medical equipment analytic data files. The Medicare 5% sample claims database can be used to conduct both cross-sectional and longitudinal studies. A unique, deidentified Medicare beneficiary identifier is assigned to each enrollee, which is used to follow them longitudinally. Several studies have been conducted using this database [8–10]. The information recorded in the claims dataset includes dates of service provided, charge and payment amounts, clinical diagnosis codes, and procedure codes. Information on demographic characteristics such as age, gender, and race/ethnicity is available in the denominator files of Medicare claims dataset.

The home healthcare files consist of fee-for-service claims for Medicare-certified home health services, service dates, claim payment amount, primary diagnosis code (ICD-9-CM codes), up to 9 other diagnosis codes, and the total number of home healthcare visits.

Study Sample. Our study sample comprised community-dwelling elderly Medicare beneficiaries aged 65 years and older, who were alive and had continuous Part A and Part B enrollment during 2006 and 2007. Medicare beneficiaries enrolled in Health Maintenance Organizations (HMO) were excluded due to unavailability of HMO claims. To be included in the final study sample, individuals with and without PD were required to have positive direct healthcare expenditures. Individuals with end-stage renal disease (ESRD) were also excluded from the final sample. The final sample size was 60,874 with 10,865 elderly Medicare beneficiaries with PD and 50,009 elderly Medicare beneficiaries without PD. The cohort development of this study is shown in Figure 1.

Figure 1: Cohort development.

2.1.3. Measures

Dependent Variable

Home Healthcare Use. Home healthcare use was identified during the follow-up period (i.e., calendar year 2007). Elderly Medicare beneficiaries with any paid home healthcare visit during the follow-up period were considered to be home health users.

Home Healthcare Expenditures. Among users of home healthcare, we examined home healthcare expenditures during follow-up period (i.e., calendar year 2007). We used actual Medicare payments to calculate home healthcare expenditures from home healthcare file. Home health expenditure was skewed to the right and, therefore, we transformed expenditures with natural logarithm.

2.2. Key Independent Variable: PD and No PD

Presence or absence of PD constituted the key independent variable for this study and this was measured during baseline period. Individuals with PD were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes of 332.xx. Use of ICD-9-CM codes from Medicare claims to identify PD has modest sensitivity (61.13%) and positive predictive value (65.13%) and the very high specificity (99.08%) [11].

2.3. Independent Variables

All independent variables were measured during the baseline period. The predisposing characteristics comprised gender (women/men), race/ethnicity (white, African American, Latino, and others), and age (65–74 and 75 years and older). Enabling characteristics consisted of public assistance (which was indicated by Medicare premiums and deductibles that were subsidized by the state keeping in view the financial status of the enrollee). The need factors comprised the number of other cooccurring comorbidities. Personal health choices consisted of substance use disorders that included alcohol, tobacco, and drug use. This domain also included baseline healthcare use. The external environment factors comprised census region and metro status.

2.3.1. Statistical Methods

Statistically significant differences in home healthcare use during follow-up period by presence of PD were ascertained with chi-square tests. Logistic regressions were used to examine the association between home healthcare use and PD after controlling for predisposing, enabling, need factors, personal health choices, and external environment.

We examined the differences in average home healthcare expenditures between PD and no PD groups by using -tests. We also conducted Ordinary Least Squares (OLS) regressions on log-transformed home healthcare expenditures during follow-up period to examine the relationship between PD and home healthcare expenditures after controlling for predisposing, enabling, need factors, personal health choices, and external environment. The relationship between home healthcare use and expenditures for each characteristic was ascertained by using chi-square tests and -tests for every characteristic between PD and no PD groups.

Postregression Decomposition Techniques. To assess the extent to which differences in home healthcare use and expenditures among individuals with and without PD can be explained by predisposing, enabling, need factors, personal health choices, and external environmental factors, we used postregression decomposition techniques. The differences in home healthcare use or expenditures between the two groups of individuals with and without PD are compartmentalized into two parts: (1) one part is attributable to the differences in characteristics, which is the explained portion of the differences, and (2) the other part is the differences attributable to differences in coefficients. The explained portion of the gap is the sum of the differences between individuals with and without PD in terms of the observed or measured characteristics weighted by the estimated coefficients of individuals with PD.

For home healthcare expenditures, we used postregression linear decomposition [12, 13]. For home healthcare use, a postregression nonlinear decomposition was used because home healthcare use was measured as a binary variable [14]. In the nonlinear decomposition, the contribution of each of the individual-level factors to the gap in terms of home healthcare use between the two groups is estimated by the change in the mean predicted probability by superimposing the distribution of elderly Medicare beneficiaries with PD on those without PD, keeping all other factors constant [14].

A common problem encountered with decomposition techniques is the “index number” problem. As the characteristics can be weighted by the regression coefficients from PD group or no PD group, the estimates of explained portion will vary. Many solutions have been proposed to overcome this problem [15–18]. For the current study we used the solution proposed by Neumark and used the estimated regression coefficients from a regression combining PD and no PD group in which presence of PD was not used as an independent variable [15].

Analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC). STATA version 13.0 was used to perform nonlinear decomposition, whereas Blinder-Oaxaca linear decomposition was performed using Microsoft Excel 2013.

3. Results

Table 1 describes the study sample overall as well as by PD status. The final study sample consisted of 60,874 elderly Medicare beneficiaries among whom 10,865 had PD and 50,009 did not have PD. Overall, the majority of the study participants comprised women (58.3%) and whites (89.8%) and were 75 years and older (51.2%). The average number of comorbidities in the overall study sample was 17.26 (±10.38). In terms of predisposing, enabling, need, personal health choice, and external environmental factors, all the characteristics were statistically significantly different between elderly Medicare beneficiaries with and without PD except for baseline substance use disorder and cancer. Among elderly Medicare beneficiaries with PD, a higher percentage were men (50.1%) and among those without PD a significantly lower percentage were men (39.9%). A greater proportion of elderly Medicare beneficiaries with PD were 75 years and older (63.9%) and a lower proportion of elderly Medicare beneficiaries without PD were 75 years and older (48.4%). The study sample consisted of an overwhelming majority of whites in both the groups (around 90% in both groups). A higher percentage of elderly Medicare beneficiaries were on public assistance among those with PD (16.0%) compared to those without PD (11.4%). Elderly Medicare beneficiaries with PD () had a significantly higher number of comorbidities compared to those without PD (). Elderly Medicare beneficiaries with PD had significantly higher rates of baseline inpatient, outpatient, hospice, skilled nursing facilities, and durable medical equipment use. An overwhelmingly higher percentage of elderly Medicare beneficiaries resided in the metro regions in both the two groups (approximately 80% in both groups). Elderly Medicare beneficiaries in both PD and no PD groups resided primarily in the Southern census region (around 38% in both groups) followed by Midwest, Northeastern, and Western regions.

Table 1: Description of study sample, overall and by Parkinson’s disease status among Medicare beneficiaries. National Medicare 5% sample, 2006-2007.

Variables
Overall
Col.%
PD
Col.%
No PD
Col.%
Sig.

= 60,874
= 10,865
= 50,009

Predisposing characteristics

Gender

    Female
35,470
58.3
5,421
49.9
30,049
60.1

    Male
25,404
41.7
5,444
50.1
19,960
39.9

Race/ethnicity

    White
54,652
89.8
10,007
92.1
44,645
89.3

    AA
3,695
6.1
425
3.9
3,270
6.5

    Others
2,527
4.2
433
4.0
2,094
4.2

Age group

    65–74
29,725
48.8
3,927
36.1
25,798
51.6

    75, +
31,149
51.2
6,938
63.9
24,211
48.4

Enabling characteristics

Public assistance

    Yes
7,445
12.2
1,742
16.0
5,703
11.4

    No
53,429
87.8
9,123
84.0
44,306
88.6

External environmental characteristics

Census region

    Northeastern
11,983
19.7
2,399
22.1
9,584
19.2

    Midwest
15,842
26.0
2,837
26.1
13,005
26.0

    South
23,323
38.3
3,931
36.2
19,392
38.8

    West
9,726
16.0
1,698
15.6
8,028
16.1

Metro status

    Metro
46,162
75.8
8,448
77.8
37,714
75.4

    No metro
14,712
24.2
2,417
22.2
12,295
24.6

Personal health practices

Substance use

    Yes
2,337
3.8
440
4.0
1,897
3.8

    No
58,537
96.2
10,425
96.0
48,112
96.2

Inpatient visit

    Yes
12,875
21.2
3,584
33.0
9,291
18.6

    No
47,999
78.8
7,281
67.0
40,718
81.4

DME visit

    Yes
19,239
31.6
4,679
43.1
14,560
29.1

    No
41,635
68.4
6,186
56.9
35,449
70.9

Hospice visit

    Yes
256
0.4
122
1.1
134
0.3

    No
60,618
99.6
10,743
98.9
49,875
99.7

SNF visit

    Yes
3,576
5.9
1,597
14.7
1,979
4.0

    No
57,298
94.1
9,268
85.3
48,030
96.0

Outpatient visit quintile

    0-0
14,403
23.7
1,708
15.7
12,695
25.4

    1-1
10,153
16.7
1,469
13.5
8,684
17.4

    2-3
13,303
21.9
2,306
21.2
10,997
22.0

    4–6
10,654
17.5
2,234
20.6
8,420
16.8

    7–178
12,361
20.3
3,148
29.0
9,213
18.4

Office visit quintile

    0–5
9,433
15.5
502
4.6
8,931
17.9

    6–10
12,697
20.9
1,335
12.3
11,362
22.7

    11–16
12,676
20.8
2,082
19.2
10,594
21.2

    17–25
12,058
19.8
2,632
24.2
9,426
18.8

    26–281
14,010
23.0
4,314
39.7
9,696
19.4

Need factor

Average
S.D.
Average
S.D.
Average
S.D.

Number of comorbidities
17.26
10.38
21.97
11.75
16.24
9.76

Note: based on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; they had a positive direct total healthcare expenditure; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some other reason were excluded from the final sample.

PD: Parkinson’s disease; AA: African American; SUD: substance use disorder; DME: durable medical equipment; HHA: Home Health Agency; SNF: skilled nursing facility; S.D.: Standard Deviation.

< .001; .001 ≤ < .01; .01 ≤ < .05.

Table 2 exhibits the relationship between predisposing, enabling, personal health choice, need, and external environmental factors and home healthcare use and average home healthcare expenditure by PD status. There were 2,445 and 4,061 elderly Medicare beneficiaries with and without PD, respectively, who had home healthcare use. Overall, 22.5% of the elderly with PD used home healthcare compared to 9.2% without PD (). This translated into a 13.3-percentage-point difference in home healthcare use. For every characteristic (except for elderly Medicare beneficiaries with skilled nursing facility visits), home healthcare use was higher among the elderly with PD compared to those without PD (Table 2). For example, the home healthcare use among women (24.9% versus 10.5%) and men (20.2% versus 7.3%) with PD was significantly higher compared to those without PD. Table 2 also summarizes the average home healthcare expenditures among home healthcare users by the presence or absence of PD. The average home healthcare expenditures among elderly Medicare beneficiaries (who used home healthcare service) with PD were 1.37 times higher compared to those without PD ($6,792 versus $4,965). Home healthcare expenditures were also significantly higher across each characteristic among the elderly with PD compared to those without PD. For example, average home healthcare expenditures among women ($7,055 versus $5,201) and men ($6,469 versus $4,453) with PD were significantly higher compared to those without PD.

Table 2: Number and percent with home healthcare use and average home healthcare expenditures among users by Parkinson’s disease status among elderly Medicare beneficiaries. National Medicare 5% sample, 2006-2007.

All
Percent with home healthcare use
Average home healthcare expenditures among users

PD
No PD
Sig.
PD
No PD
Sig.

2,445
22.5
4,601
9.2

$6,792
$6,640
$4,965
$5,537

Predisposing characteristics

Gender

    Female
1,348
24.9
3,148
10.5

$7,055
$198
$5,201
$108

    Male
1,097
20.2
1,453
7.3

$6,469
$227
$4,453
$149

Race/ethnicity

    White
2,202
22.0
3,933
8.8

$6,556
$144
$4,601
$86

    AA
135
31.8
447
13.7

$8,965
$648
$6,639
$312

    Others
108
24.9
221
10.6

$8,904
$1,268
$8,048
$726

Age group

    65–74
679
17.3
1,417
5.5

$6,545
$288
$4,622
$164

    75, +
1,766
25.5
3,184
13.2

$6,887
$173
$5,117
$103

Enabling characteristic

Public assistance

    Yes
392
22.5
875
15.3

$8,368
$514
$6,785
$286

    No
2,053
22.5
3,726
8.4

$6,491
$142
$4,537
$84

External environmental characteristics

Census regions

    Northeastern
562
23.4
996
10.4

$5,832
$261
$3,800
$157

    Midwest
529
18.6
1,010
7.8

$5,901
$219
$4,080
$128

    South
1,031
26.2
1,999
10.3

$7,958
$278
$6,120
$162

    West
323
19.0
596
7.4

$6,205
$308
$4,536
$182

Metro status

    Metro
1,986
23.5
3,584
9.5

$6,890
$174
$4,997
$104

    No metro
459
19.0
1017
8.3

$6,372
$270
$4,852
$150

Personal health choice

Substance use disorder

    Yes
126
28.6
275
14.5

$6,385
$544
$5,190
$305

    No
2,319
22.2
4,326
9.0

$6,814
$154
$4,950
$91

Inpatient visit

    Yes
1,141
31.8
1,866
20.1

$7,971
$268
$5,699
$165

    No
1,304
17.9
2,735
6.7

$5,761
$160
$4,464
$91

DME visit

    Yes
1,499
32.0
2,377
16.3

$7,766
$236
$5,891
$147

    No
946
15.3
2,224
6.3

$5,250
$143
$3,974
$78

Hospice visit

    Yes
19
15.6
23
17.2

$6,542
$2,600
$6,286
$1,749

    No
2,426
22.6
4,578
9.2

$6,794
$149
$4,958
$88

SNF visit

    Yes
499
31.2
567
28.7

$8,133
$423
$6,314
$290

    No
1,946
21.0
4,034
8.4

$6,449
$158
$4,775
$90

Outpatient visit quintile

    0-0
313
18.3
809
6.4

$6,818
$392
$4,991
$207

    1-1
303
20.6
668
7.7

$7,176
$501
$5,104
$280

    2-3
514
22.3
972
8.8

$6,791
$325
$4,942
$191

    4–6
545
24.4
860
10.2

$6,557
$257
$4,553
$160

    7 and higher
770
24.5
1,292
14.0

$6,798
$275
$5,167
$168

Office visit quintile

    0–5
72
14.3
387
4.3

$4,786
$478
$4,134
$189

    6–10
206
15.4
630
5.5

$5,457
$343
$4,496
$170

    11–16
372
17.9
816
7.7

$6,037
$308
$4,637
$172

    17–25
570
21.7
1,048
11.1

$6,089
$246
$4,758
$146

    26 and higher
1,225
28.4
1,720
17.7

$7,691
$275
$5,604
$177

Need factors

Number of comorbidities

    <=16
623
15.4
1,552
5.3

$5,649
$195
$4,207
$104

    >16
1,822
26.8
3,049
14.8

$7,183
$1,942
$5,350
$118

Note: based on 2,445 and 4,601 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some other reason were excluded from the final sample. Average home healthcare expenditures were estimated among users of home healthcare.

S.E.: Standard Errors; PD: Parkinson’s disease; AA: African Americans; DME: durable medical equipment; SNF: skilled nursing facility.

< .001; .001 ≤ < .01; .01 ≤ < .05.

Table 3 summarizes the findings from the logistic regression analyses of home healthcare use and OLS regressions analyses on log-transformed home healthcare expenditures on a pooled sample among elderly Medicare beneficiaries who had used home healthcare. It was observed that, after controlling for predisposing, enabling, need, personal health choice, and external environmental factors, elderly individuals with PD were more than two times (Adjusted Odds Ratio: 2.12; 95% Confidence Interval: 1.99–2.25) as likely to have home healthcare use as those without PD. It can be noted from the OLS regression analyses that elderly Medicare beneficiaries with PD had 39% (calculated using the formula ) higher home healthcare expenditure compared to those without PD.

Table 3: Adjusted Odds Ratios and 95% Confidence Intervals from logistic regression on home healthcare use and parameter estimates from OLS regression on log-transformed home healthcare expenditures among users. National Medicare 5% sample, 2006-2007.

AOR
95% CI
Sig.
Beta
S.E.
Sig.

Intercept
—
—
—
7.627
0.073

Parkinson's disease

    Yes
2.12
1.99, 2.25

0.333
0.024

    No

Predisposing characteristics

Gender

    Female
1.30
1.23, 1.37

0.123
0.024

    Male

Race/ethnicity

    White

    AA
1.52
1.37, 1.68

0.279
0.043

    Others
1.13
0.98, 1.29

0.170
0.057

Age group

    75, +
2.11
1.99, 2.23

−0.127
0.025

    65–74

Enabling characteristics

Public assistance

    Yes
1.17
1.08, 1.26

0.128
0.032

    No

External environmental characteristics

Census region

    Northeastern
1.29
1.18, 1.41

−0.098
0.040

    Midwest
1.03
0.94, 1.13

−0.156
0.040

    South
1.40
1.29, 1.52

0.196
0.036

    West

Metro status

    Metro
1.14
1.06, 1.21

0.075
0.029

    No metro

Personal health choice

Substance use

    Yes
1.11
0.98, 1.25

−0.004
0.050

    No

Outpatient visit quintile

    0-0
1.06
0.96, 1.16

0.120
0.040

    1-1
1.08
0.99, 1.19

0.111
0.040

    2-3
1.08
0.99, 1.17

0.057
0.034

    4–6
1.08
1.00, 1.17

−0.001
0.034

    7 or higher

Office visit quintile

    0–5
0.87
0.76, 1.00

−0.071
0.062

    6–10
0.87
0.78, 0.97

−0.021
0.048

    11–16
0.96
0.87, 1.05

−0.009
0.040

    17–25
1.05
0.97, 1.14

−0.037
0.033

    26 or higher

SNF visits
0.88
0.85, 0.91

0.052
0.012

Inpatient visits
1.22
1.18, 1.26

0.033
0.013

Hospice visits
0.97
0.93, 1.01

0.001
0.016

DME visits
1.05
1.05, 1.06

0.016
0.002

Need factors

Number of comorbidities
1.04
1.03, 1.04

0.006
0.002

Note: logistic regression conducted on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; they had a positive direct total healthcare expenditure; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some other reason were excluded from the final sample.

Ordinary Least Squares regression conducted on 2,445 and 4,601 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson’s disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled in Health Maintenance Organizations during 2006 and 2007; they were home healthcare users; individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some other reason were excluded from the final sample.

OLS: Ordinary Least Squares; S.E.: Standard Errors; PD: Parkinson’s disease; AA: African Americans; SUD: substance use disorder; DME: durable medical equipment; SNF: skilled nursing facility.

< .001; .001 ≤ < .01; .01 ≤ < .05.

Table 4 summarizes the results from the nonlinear and linear decomposition on the home healthcare use (yes/no) and expenditures. There was a 13.3-percentage-point difference in home healthcare use between these two groups in terms of home healthcare use. From the multivariate decomposition analysis, it was observed that, out of the 13.3-percentage-point difference in home healthcare use among elderly Medicare beneficiaries, a 3.64-percentage-point difference was explained by the individual-level variables included in this study. Thus, a 27.5% difference in home healthcare use among elderly Medicare beneficiaries with and without PD was explained by the predisposing, enabling, need, personal health choice, and external environmental factors. Need characteristics (physical and mental health conditions and baseline resource use) of the elderly Medicare beneficiaries explained the highest (approximately 65%) proportion of the home healthcare use differences between elderly Medicare beneficiaries with and without PD.

Table 4: Nonlinear and linear decomposition of home healthcare use and expenditures. Elderly Medicare beneficiaries with and without PD. Medicare 5% claims database (2006, 2007).

% with home healthcare use (PD)
% with home healthcare use (no PD)
22.5% 
9.2%

Average log-transformed home healthcare expenditures (PD)

8.44

Average log-transformed home healthcare expenditures (no PD)

8.09

Difference
13.3
0.35

Total explained
3.64
0.063

Nonlinear decomposition
Linear decomposition

Predisposing characteristics

    Gender, race/ethnicity, age
5.3%
1.8%

Enabling characteristic

    Public assistance
−1.5%
1.6%

Need characteristic

    Number of comorbidities
17.5%
4.1%

Personal health choices

    Any type of SUD
    Baseline resource use
6.0%
12.6%

External environmental factors

    Census region
    Metro status
0.2%
−2.1%

Explained to total difference
27.5%
18.0%

Unexplained portion
72.5%
82.0%

Note: nonlinear decomposition analysis based on 10,865 and 50,009 elderly (age 65 or older) Medicare beneficiaries with and without PD.

Difference in home healthcare use = 13.3 percentage points. Percentage points in home healthcare use are explained by each independent variable. The percentage explained is derived by dividing the total explained portion by the 13.3-percentage-point difference between elderly Medicare beneficiaries with and without PD.

Linear decomposition analysis based on 2,445 and 4,601 elderly (age 65 or older) Medicare beneficiaries with and without PD and who used home healthcare.

SUD: substance use disorder; Exp.: expenditure.

Table 4 also displays the results of linear decomposition of home healthcare expenditures among elderly Medicare beneficiaries with and without PD. We restricted these analyses to users of home healthcare. The mean log-transformed home healthcare expenditure among elderly Medicare beneficiaries with and without PD was 8.44 and 8.09 units, respectively. This translated into a 0.35-unit difference in mean log-transformed home healthcare expenditure. Using pooled regression coefficients, 18% of the home healthcare expenditures differences among elderly Medicare beneficiaries with and without PD were explained, while the remaining majority (82%) of the home healthcare expenditure differences remained unexplained. It was observed that baseline personal health choices explained the highest proportion of the home healthcare expenditure differences followed by need factors. Using the pooled weights, it can be inferred that if the baseline personal health choices were similar between elderly Medicare beneficiaries with and without PD, then the home healthcare expenditure would decrease by 12.6%. The negative coefficient of the enabling characteristic signifies that if the gender, race/ethnicity, and age characteristics of elderly Medicare beneficiaries with and without PD were similar, then the difference in home healthcare use would increase by the respective percentage units.

4. Discussion

The present study examined the magnitude of the difference in home healthcare resource use and expenditures among elderly Medicare beneficiaries with and without PD. This study also evaluated the extent to which predisposing, enabling, need, personal health choices, and external environmental factors explained the differences among elderly Medicare beneficiaries with and without PD. It was observed that, after adjusting for the predisposing, need, personal health choice, and external environmental factors, elderly Medicare beneficiaries with PD had 13.3% higher home healthcare use and 39% higher home healthcare expenditures (among users) compared to those without PD. Previous studies have consistently found that home healthcare use and expenditure among individuals with PD are significantly higher among individuals with PD [1–4]. However, no study examined the factors associated with higher home healthcare use and expenditures among elderly individuals with PD and to what extent the individual-level factors explain such differences. The unique contribution of this study is providing an assessment of the extent to which these individual-level factors explained the use and expenditure differences using a nationally representative sample of Medicare beneficiaries.

Approximately 27% and 18% of the home healthcare use and expenditure differences among elderly Medicare beneficiaries with and without PD were explained by the individual-level factors adjusted in this study. The need characteristics such as baseline comorbidities and personal health choices such as baseline resource use explained the highest proportion of the explained differences. The high unexplained portions for home healthcare use (72.5%) and expenditure (82%) difference between elderly Medicare beneficiaries with and without PD can be due to several factors such as severity and duration of PD, medication adherence, and inclination towards seeking healthcare. Moreover, the presence or absence of a caregiver for elderly Medicare beneficiaries with PD can also be a contributing factor to the difference.

Findings from this study have profound implications for healthcare providers, payers, and patients. Findings from the decomposition analysis identified the factors that contribute to the excess burden of home healthcare among elderly Medicare beneficiaries with PD. The study findings can be useful to the Centers for Medicare and Medicaid Services (CMS) in formulating programs and policies that can help reduce home healthcare use and expenditures among elderly Medicare beneficiaries with PD, thereby having a potential to bend the ever increasing Medicare cost curve. For example, the decomposition analyses in this study showed that one of the major drivers of home healthcare expenditure is the presence of baseline comorbidities. CMS agency is currently implementing reimbursement policies that can encourage management of Medicare beneficiaries with multiple chronic conditions. The study findings are important for providers as well as suggesting a need for collaborative care among different specialists such as neurologists, endocrinologists, and mental health specialists to provide a complete and holistic care to these elderly individuals with chronic diseases. Our study findings reinforce the implementation of an integrated delivery system (IDS) where primary physicians serve as the gate-keeper and maintain a good referral system, which can also be helpful in treating elderly individuals with multiple chronic conditions. In light of the recent Affordable Care Act (ACA), there is emphasis on team-based approaches such as Patient Centered Medical Home (PCMH) where continuous and well-coordinated care is provided by a team of healthcare providers [19]. The aims of these PCMHs are to provide evidence based treatments for acute and chronic conditions, as well as providing preventive services. These types of care models can be beneficial to the elderly patients as they have the potential to improve health outcomes, which in turn can reduce service use and expenditures. Such models can also reduce the out-of-pocket spending for the patients while improving their health outcomes.

The study strengths are large sample size, representative sample, and comprehensive list of variables. While interpreting the findings the following limitations need to be noted. The findings from this study are not generalizable to other populations or settings. HMO enrollees are excluded from the study sample. Users of home healthcare may be different from nonusers of home healthcare in unobserved variables. Our study does not control for such selection bias. Five percent Medicare sample did include many variables that are associated with home healthcare use. This may lead to underestimation of the explained portion of the estimated differences in home healthcare expenditures among individuals with and without PD. However, by using a representative sample of Medicare beneficiaries with linked Medicare claims, we were able to estimate the extent to which unmeasured factors can underestimate explained portion of the differences in expenditures among individuals with and without PD.

5. Conclusion

Notwithstanding the limitations, this study examined the magnitude of the difference in home healthcare resource use and expenditure among elderly Medicare beneficiaries with and without PD and also evaluated the extent to which predisposing, enabling, need, personal health choice, and external environmental factors explained these differences. Elderly individuals with PD had 13.3% and 39% higher home healthcare use and expenditure compared to those without PD. Individual-level factors used in this study explained 27.5% and 18% of the differences in home healthcare use and expenditures, respectively. Future studies should compare the home healthcare use and expenditure among elderly individuals with PD compared to other neurodegenerative diseases (e.g., Alzheimer’s disease) and include some of the factors such as functional status, informal caregiving, severity of chronic conditions, and medication use, to understand their influence on the home healthcare use and expenditures.

Disclosure

A part of this project will be presented as an oral presentation at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, May 16–20, 2015, Philadelphia, USA.

Disclaimer

The content of the paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Conflict of Interests

Drs. Sandipan Bhattacharjee, Aaron Metzger, Cindy Tworek, Xiaoyun Pan, and Usha Sambamoorthi do not have any conflict of interests regarding the publication of this paper. Dr. Wenhui Wei is an employee and stock holder of Sanofi US LLC.

Acknowledgments

Dr. Sandipan Bhattacharjee received research assistance and Dr. Usha Sambamoorthi was partially supported for infrastructure from the West Virginia Collaborative Health Outcomes Research of Therapies and Services (WV CoHORTS) Center. This project was partially supported by the National Institute of General Medical Sciences, U54GM104942. The authors would like to thank Dr. Suresh Madhavan for providing access to the Medicare 5% sample claims database.

References

S. Bhattacharjee and U. Sambamoorthi, “Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis,” Parkinsonism & Related Disorders, vol. 19, no. 8, pp. 746–750, 2013.

K. Noyes, H. Liu, Y. Li, R. Holloway, and A. W. Dick, “Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries,” Movement Disorders, vol. 21, no. 3, pp. 362–372, 2006.

J. C. Pressley, E. D. Louis, M.-X. Tang et al., “The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism,” Neurology, vol. 60, no. 1, pp. 87–93, 2003.

L. M. Rubenstein, E. A. Chrischilles, and M. D. Voelker, “The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey,” PharmacoEconomics, vol. 12, no. 4, pp. 486–498, 1997.

Medicare Payment Advisory Commission (MedPAC), Report to the Congress: Medicare Payment Policy, chapter 9, Home Health Care Services, 2014, http://www.medpac.gov/documents/reports/mar14_ch09.pdf?sfvrsn=0.

R. M. Andersen, “Revisiting the behavioral model and access to medical care: does it matter?” Journal of Health and Social Behavior, vol. 36, no. 1, pp. 1–10, 1995.

Centers for Medicare & Medicaid Services (CMS), “National Claims History (NCH) Standard Analytical Files,” 2014, http://aspe.hhs.gov/datacncl/datadir/cms.htm

K. J. Bozic, E. Lau, S. Kurtz et al., “Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in medicare patients,” The Journal of Bone & Joint Surgery—American Volume, vol. 94, no. 9, pp. 794–800, 2012.

K. J. Bozic, K. Ong, E. Lau et al., “Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality,” Clinical Orthopaedics and Related Research, vol. 471, no. 2, pp. 574–583, 2013.

J. J. Escarce and T. G. McGuire, “Methods for using Medicare data to compare procedure rates among Asians, blacks, Hispanics, Native Americans, and whites,” Health Services Research, vol. 38, no. 5, pp. 1303–1317, 2003.

K. Noyes, H. Liu, R. Holloway, and A. W. Dick, “Accuracy of medicare claims data in identifying Parkinsonism cases: comparison with the medicare current beneficiary survey,” Movement Disorders, vol. 22, no. 4, pp. 509–514, 2007.

R. Oaxaca, “Male-female wage differentials in urban labor markets,” International Economic Review, vol. 14, no. 3, pp. 693–709, 1973.

A. S. Blinder, “Wage discrimination: reduced form and structural estimates,” The Journal of Human Resources, vol. 8, no. 4, pp. 436–455, 1973.

R. W. Fairlie, “An extension of the Blinder-Oaxaca decomposition technique to logit and probit models,” Journal of Economic and Social Measurement, vol. 30, no. 4, pp. 305–316, 2005.

D. Neumark, “Employers’ discriminatory behavior and the estimation of wage discrimination,” The Journal of Human Resources, vol. 23, no. 3, pp. 279–295, 1988.

J. Cotton, “On the decomposition of wage differentials,” Review of Economics and Statistics, vol. 70, no. 2, pp. 236–243, 1988.

R. L. Oaxaca and M. R. Ransom, “Identification in detailed wage decompositions,” Review of Economics and Statistics, vol. 81, no. 1, pp. 154–157, 1999.

C. W. Reimers, “Labor market discrimination against hispanic and black men,” Review of Economics and Statistics, vol. 65, no. 4, pp. 570–579, 1983.

Patient Centered Medical Home (PCMH), 2014, http://www.acponline.org/advocacy/state_health_policy/hottopics/pcmh.pdf